VTE in cancer patients is associated with increased morbidity and mortality. Recent review in JCO.
Consensus:
1)Prolonged prophylaxis for hospitalised high risk surgical patients
2) prophylaxis not recommended for ambulatory cancer patients or fir central lines
3)LMH is preferred for long term treatment of VTE